Ocular gene therapy

Ocular gene therapy

  • CN 101,637,611 A
  • Filed: 08/27/2003
  • Published: 02/03/2010
  • Est. Priority Date: 08/28/2002
  • Status: Active Application
First Claim
Patent Images

1. the endostatin code nucleic acid as an expression vector part of expressing endostatin in suitable host is used for suppressing the purposes of retinal vessel permeability with the medicine of treatment retinal diseases in preparation.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×